Asosiy kontentga oʻtish
Maqola

Semizlik fonida jigar fibrozining rivojlanish mexanizmlari va erta noinvaziv diagnostikaning zamonaviy imkoniyatlari: adabiyotlar sharhi

2026uz
ABI

Annotatsiya

Obesity is one of the most prevalent metabolic health problems worldwide and a major risk factor for metabolic dysfunction-associated steatotic liver disease (MASLD). MASLD may progress from simple steatosis to metabolic dysfunction-associated steatohepatitis (MASH), liver fibrosis, cirrhosis, and hepatocellular carcinoma. The presence and severity of liver fibrosis are particularly important determinants of disease prognosis. In obesity, visceral adipose tissue dysfunction, insulin resistance, excessive influx of free fatty acids into the liver, de novo lipogenesis, lipotoxicity, oxidative stress, mitochondrial dysfunction, and chronic inflammation contribute to the activation of fibrogenesis. The principal effector cells involved are hepatic stellate cells (HSCs), whose activation leads to excessive accumulation of extracellular matrix (ECM) components, particularly type I and type III collagen. This literature review aims to analyse the pathogenic mechanisms underlying liver fibrosis development in obesity and evaluate the current capabilities of non-invasive methods for early fibrosis detection, including the Fibrosis-4 (FIB-4) index, the Enhanced Liver Fibrosis (ELF) test, and elastography.

Identifikatorlar

Iqtiboslar va manbalar